FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: biotech

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

CENTERVILLE, MA ? January 24, 2011 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") announced today that the Company's flagship product, the ViraTech UV-400 indoor air purifier, is now being distributed through the Perfect Touch Beauty Network ("Perfect Touch") targeting the growing need for improved air quality at beauty salons across the country.

CENTERVILLE, MA ? January 20, 2011 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce one of UV Flu's distributors, INE Global, has placed an order with The Rogerson House, one of Boston's pre-eminent Assisted Living Facilities.

CENTERVILLE, MA ? January 19, 2011 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") announced today that the Company will commence shipments this week to its newest Asian distributor, Ormed Systems ("Ormed") of Mumbai, India, for distribution to the Medical and Hospitality marketplace throughout the subcontinent.

POINT ROBERTS, Wash., January 12 , 2011 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research including biotech stocks, updates investors with content and stock directories to research the industry for 2011.

LINCOLNSHIRE, Ill. - January 10, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc.

CENTERVILLE, MA ? January 5, 2011 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce the availability of the ViraTech UV-400 air purifier on two new sales websites, and that the Company is in talks to feature the product on a number of other e-commerce providers as early as the end of January.

LINCOLNSHIRE, Ill. - December 31, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced closing of a previously announced sale of an aggregate of $18 million of securities in a registered direct offering. BioSante received net proceeds of approximately $16.9 million after deducting placement agent fees and other offering expenses.

Point Roberts, WA - December 28, 2010 (Investorideas.com Newswire) - InvestorIdeas.com, a leader in sector research for investors including biotech stocks, issues a trading alert for BioSante Pharmaceuticals, Inc . (NASDAQ:BPAX). The stock closed at $2.00, up $0.4250 (26.98%) on 10,565,686 shares. The stock was down $0.25 in after hours trading.

LINCOLNSHIRE, Ill. - December 28, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received commitments from several institutional investors to purchase $18 million of securities in a registered direct offering.

Point Roberts, WA – December 15, 2010 (Investorideas.com Newswire) - InvestorIdeas.com, a
leader in sector research for investors including biotech and pharma stocks , reports on recent
Volume Leading Biotech/ Pharma Stocks news and trading for December 15th for NASDAQ and
microcap stocks.

Pages

ADVERTISE WITH US